Top

Published in:

01-12-2011 | Original Paper

Expression of p16 in Sinonasal Undifferentiated Carcinoma (SNUC) Without Associated Human Papillomavirus (HPV)

Authors: Beth Wadsworth, Jeffery M. Bumpous, Alvin W. Martin, Michael R. Nowacki, Alfred B. Jenson, Hanan Farghaly

Published in: Head and Neck Pathology | Issue 4/2011

Abstract

Sinonasal undifferentiated carcinoma (SNUC) is an uncommon and highly aggressive neoplasm of the paranasal sinuses and nasal cavity. Its undifferentiated histologic appearance often requires immunohistochemical studies to distinguish it from other high-grade neoplasms. Due to the rarity of SNUC, its immunohistochemical staining profile has been incompletely characterized, and little work has been done on its expression of the markers for human papillomavirus (HPV). Our objective is to expand our knowledge of its immunophenotype and its association with HPV in order to define markers with mechanistic potential in the disease process, or of possible therapeutic importance. A total of five patients (one woman and four men) with SNUC, ranging in age from 26 to 75 years (mean 56.8 years) were compared to five patients (five men) with poorly differentiated squamous cell carcinoma (PDSCC), ranging in age from 53 to 75 years (mean 62.2 years). PDSCC was chosen as a control, given its well-reported immunohistochemical profile and negativity for HPV markers. The immunohistochemical panel included: CK7, CK19, EMA, NSE, chromogranin, p53, CK5/6, p63, CK14, S100, HMB-45, desmin, muscle specific actin, and CD45. Additionally, tests for p16, EBV, and HPV (subtypes 6, 11 16, 18) were performed. The diagnosis of SNUC was confirmed in all cases by histology and immunohistochemical stains. An interesting finding of strong diffuse positivity for p16 was noted in all SNUC cases, compared to only two of five PDSCC that were positive for p16. HPV DNA was not detected in any SNUC cases or any cases of PDSCC. All SNUC cases demonstrated over expression of p16 in the absence of HPV DNA expression. This may represent residual epithelial p16 staining, which is normally present in the sinonasal tract. Due to the rarity of SNUC, more cases will need to be evaluated to confirm the absence of HPV DNA.

Frierson HF Jr. Sinonasal undifferentiated carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumors. Lyon: IARC Press; 2005. p. 19.

Pilch BZ. Tumors of the upper respiratory tract, part B: larynx and trachea. In: Fletcher CD, editor. Diagnostic histopathology of tumors. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2007. p. 112–5.

Hunt JL, Barnes L. Immunohistology of head and neck neoplasms. In: Dabbs D, editor. Diagnostic immunohistochemistry. 2nd ed. Philadelphila, PA: Churchill Livingstone; 2006. p. 232–5.

Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32(6):828–34.PubMedCrossRef

Desai PC, Jaglal MV, Gopal P, et al. Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study. Exp Mol Pathol. 2009;87(2):94–8.PubMedCrossRef

Frierson HF Jr, Mills SE, Fechner RE, et al. Sinonasal undifferentiated carcinoma: an aggressive neoplasm derived from Schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol. 1986;10(11):771–9.PubMedCrossRef

Smith SR, Som P, Fahmy A, et al. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope. 2000;110(10 Pt 1):1617–22.PubMedCrossRef

Franchi A, Moroni M, Massi D, et al. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol. 2002;26(12):1597–604.PubMedCrossRef

Cerilli LA, Holst VA, Brandwein MS, et al. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol. 2001;25(2):156–63.PubMedCrossRef

10.

Dunn ST, Clark GD, Cannon TC, et al. Survey of sinonasal inverted papillomata for Epstein-Barr virus. Head Neck. 1997;19(2):98–106.PubMedCrossRef

11.

Jeng YM, Sung MT, Fang CL, et al. Sinonasal undifferentiated carcinoma and nasopharyngeal-type carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol. 2002;26(3):371–6.PubMedCrossRef

12.

Gallo O, Di Lollo S, Graziani P, et al. Detection of Epstein-Barr virus genome in sinonasal undifferentiated carcinoma by use of in situ hybridization. Otolaryngol Head Neck Surg. 1995;112:659–64.PubMedCrossRef

13.

Major T, Szarka K, Sziklai I, et al. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol. 2005;58(1):51–5.PubMedCrossRef

14.

Reidy PM, Dedo HH, Rabah R, et al. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope. 2004;114(11):1906–9.PubMedCrossRef

15.

Syrjänen KJ. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol. 2003;56(3):174–81.PubMedCrossRef

16.

Syrjänen S. Human papillomaviruses in head and neck carcinomas. N Engl J Med. 2007;356(19):1993–5.PubMedCrossRef

17.

El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29(10):1367–72.PubMedCrossRef

18.

Rassekh CH, Rady PL, Arany I, et al. Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Laryngoscope. 1998;108(3):362–7.PubMedCrossRef

19.

Ritchie JM, Smith EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104(3):336–44.PubMedCrossRef

20.

Badaracco G, Rizzo C, Mafera B, et al. Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncol Rep. 2007;17(4):931–9.PubMed

21.

Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus—positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–9.PubMedCrossRef

22.

Klussmann JP, Mooren JJ, Lehnen M, et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res. 2009;15(5):1779–86.PubMedCrossRef

23.

D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–56.PubMedCrossRef

24.

Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120(8):1731–8.PubMedCrossRef

25.

McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck. 1998;20(3):250–65.PubMedCrossRef

26.

Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res. 2007;86(2):104–14. Review.PubMedCrossRef

27.

Pietruszewska W, Rieske P, Murlewska A, et al. Expression of p16 and protein in the evaluation of dynamics of laryngeal cancer growth. Otolaryngol Pol. 2004;58(1):173–80.PubMed

28.

Holladay EB, Logan S, Arnold J, et al. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia. Cancer. 2006;108(6):451–61.PubMedCrossRef

29.

Serrano M. The tumor suppressor protein p16INK4a. Exp Cell Res. 1997;237(1):7–13.PubMedCrossRef

30.

Schwerer MJ, Sailer A, Kraft K, et al. Expression of retinoblastoma gene product in respiratory epithelium and sinonasal neoplasms: relationship with p16 and cyclin D1 expression. Histol Histopathol. 2003;18(1):143–51.PubMed

31.

Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003;162:747–53.PubMedCrossRef

32.

Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121(11):2465–72.PubMedCrossRef

33.

Gorelick J, Ross D, Marentette L, et al. Sinonasal undifferentiated carcinoma: a case series and review of the literature. Neurosurgery. 2000;47(3):750–5.PubMed

34.

Thompson L. Malignant neoplasms of the nasal cavity, paranasal sinuses, and nasopharynx. In: Thompson L, editor. Head and neck pathology. Philadelphia: Churchill Livingstone; 2006. p. 168–71.

Title: Expression of p16 in Sinonasal Undifferentiated Carcinoma (SNUC) Without Associated Human Papillomavirus (HPV)
Authors: Beth Wadsworth
Jeffery M. Bumpous
Alvin W. Martin
Michael R. Nowacki
Alfred B. Jenson
Hanan Farghaly
Publication date: 01-12-2011
Publisher: Springer US
Published in: Head and Neck Pathology / Issue 4/2011
Electronic ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-011-0285-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Expression of p16 in Sinonasal Undifferentiated Carcinoma (SNUC) Without Associated Human Papillomavirus (HPV)

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

Central Giant Cell Lesion

Metastatic Tumors to the Oral Cavity: A Clinical Study of 18 Cases

Muscle Invasion in Oral Tongue Squamous Cell Carcinoma as a Predictor of Nodal Status and Local Recurrence: Just as Effective as Depth of Invasion?

Lymphoepithelial Carcinoma: Two Case Reports and a Systematic Review of Oral and Sinonasal Cases

Salivary Oncocytic Cystadenoma with Intraluminal Crystalloids: a Case Report with Review of the Literature

Carcinoma ex Pleomorphic Adenoma of the Nasal Cavity